[22]
Morgan, D.O. The cell cycle: principles of control. Yale J. Biol. Med., 2007, 80(3), 141-142.
[25]
Matsushime, H.; Ewen, M.E.; Strom, D.K.; Kato, J-Y.; Hanks, S.K.; Roussel, M.F.; Sherr, C.J. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell, 1992, 71(2), 323-334.
[26]
Meyerson, M.; Harlow, E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 1994, 14(3), 2077-2086.
[29]
Ren, S.; Rollins, B.J. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell, 2004, 117(2), 239-251.
[30]
Zheng, D.; Cho, Y-Y.; Lau, A.T.; Zhang, J.; Ma, W-Y.; Bode, A.M.; Dong, Z.J.C.r Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation. Cancer Res., 2008, 68(18), 7650-7660.
[31]
Fisher, R.P. Secrets of a double agent: CDK7 in cell-cycle control and transcription. J. Cell Sci., 2005, 118(22), 5171-5180.
[32]
Kaldis, P. The cdk-activating kinase (CAK): from yeast to mammals. Cell. Mol. Life Sci., 1999, 55(2), 284-296.
[34]
Loyer, P.; Trembley, J.H.; Katona, R.; Kidd, V.J.; Lahti, J.M. Role of CDK/cyclin complexes in transcription and RNA splicing. Cell. Signal., 2005, 17(9), 1033-1051.
[35]
Romano, G.; Giordano, A. Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases. Cell Cycle, 2008, 7(23), 3664-3668.
[37]
Guen, V.J.; Gamble, C.; Flajolet, M.; Unger, S.; Thollet, A.; Ferandin, Y.; Superti-Furga, A.; Cohen, P.A.; Meijer, L.; Colas, P. CDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndrome. Proc. Natl. Acad. Sci. USA, 2013, 110(48), 19525-19530.
[38]
Li, S.; MacLachlan, T.K.; De Luca, A.; Claudio, P.P.; Condorelli, G.; Giordano, A. The cdc-2-related kinase, PISSLRE, is essential for cell growth and acts in G2 phase of the cell cycle. Cancer Res., 1995, 55(18), 3992-3995.
[39]
Liu, X.; Cheng, C.; Shao, B.; Wu, X.; Ji, Y.; Lu, X.; Shen, A. LPS-stimulating astrocyte-conditioned medium causes neuronal apoptosis via increasing CDK11(p58) expression in PC12 cells through downregulating AKT pathway. Cell. Mol. Neurobiol., 2013, 33(6), 779-787.
[40]
Wilkinson, S.; Croft, D.R.; O’Prey, J.; Meedendorp, A.; O’Prey, M.; Dufès, C.; Ryan, K.M. The cyclin-dependent kinase PITSLRE/CDK11 is required for successful autophagy. Autophagy, 2011, 7(11), 1295-1301.
[41]
Blazek, D.; Kohoutek, J.; Bartholomeeusen, K.; Johansen, E.; Hulinkova, P.; Luo, Z.; Cimermancic, P.; Ule, J.; Peterlin, B.M. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev., 2011, 25(20), 2158-2172.
[42]
Li, X.; Chatterjee, N.; Spirohn, K.; Boutros, M.; Bohmann, D. Cdk12 is a gene-selective RNA polymerase II kinase that regulates a subset of the transcriptome, including Nrf2 target genes. Sci. Rep., 2016, 6, 21455.
[60]
Reeder, J.G.; Vogel, V.G. Breast cancer prevention.InAdvances in Breast Cancer Management, 2nd ed; Springer, 2008, pp. 149-164.
[67]
Gerger, A.; Langsenlehner, U.; Renner, W.; Weitzer, W.; Eder, T.; Yazdani-Biuki, B.; Hofmann, G.; Samonigg, H.; Krippl, P. A multigenic approach to predict breast cancer risk. Breast Cancer Res. Treat., 2007, 104(2), 159-164.